This inventor holds 1 USPTO granted patent. Top assignee: Kabi Pharmacia Aktiebolag. Active years: 1994.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1994
Title: Kerstin Strandgarden: Innovator in Immunomodulating Compounds
Introduction
Kerstin Strandgarden is a notable inventor based in Vallakra, Sweden. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with immunomodulating activity. Her work is characterized by a focus on innovative chemical derivatives that have potential therapeutic applications.
Latest Patents
Kerstin holds a patent for "Derivatives of quinoline-3-carboxanilide." This patent includes compounds represented by a specific formula, wherein various groups are selected from hydrogen, hydroxy, and methoxy. The compounds are designed to exhibit immunomodulating activity, showcasing her commitment to advancing medical science.
Career Highlights
Kerstin is associated with Kabi Pharmacia Aktiebolag, a company known for its dedication to pharmaceutical innovation. Her role at the company has allowed her to explore and develop new compounds that can potentially improve health outcomes.
Collaborations
Throughout her career, Kerstin has collaborated with esteemed colleagues such as Per O Gunnarsson and Torbjorn Stalhandske. These partnerships have contributed to her success and the advancement of her research.
Conclusion
Kerstin Strandgarden is a pioneering inventor whose work in immunomodulating compounds has the potential to impact the pharmaceutical industry significantly. Her dedication to innovation and collaboration continues to drive her success in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile